Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 98

Liran lures series B funding

Susquehanna International Group and Hupu returned to back a $23.2m round for the men’s grooming brand after previously supplying it with capital in 2020.

Jan 22, 2021

Make Essense makes up series B round

SIG and Hupu have returned to take part in a $23.2m round for the men’s cosmetics provider, having respectively backed its series A and A-plus rounds last year.

Jan 22, 2021

Corporate venturing deal net: 18-22 January 2021

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jan 22, 2021

Aerobotics adds series B funding

Naspers Foundry led a $17m round for Aerobotics, a developer of tree-health monitoring technology, having invested last May.

Jan 22, 2021

Remynd boosts series B

The KU Leuven spinout has completed another tranche of funding for its series B round featuring investments from the university.

Jan 21, 2021

Groove X tunes into $26m series B3 round

Hitachi Global Life Solutions, Sompo and NTT Docomo provided the cash for the creator of a family companion robot called Lovot, taking its total funding to $128m.

Jan 21, 2021

Verve Therapeutics turns to $94m series B

Novo and GV participated in a round that lifted the Harvard, Broad Institute and Penn-linked heart disease drug developer's overall funding to more than $215m.

Jan 20, 2021

Verve Therapeutics turns to $94m series B

Novo and existing backer GV participated in a round that lifted the heart disease drug developer's overall funding to more than $215m.

Jan 20, 2021

Verizon leads Vdoo series B to $57m

Verizon Ventures was among the investors that added $25m to a round already featuring Dell Technologies Capital, MS&AD Ventures and NTT Docomo Ventures.

Jan 19, 2021

BlueSphere Bio brings in series B funding

UPMC-backed cancer immunotherapy developer BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target for its close.

Jan 19, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here